Collegium Pharmaceutical sees FY24 net product revenues of $620M-$635M
The Fly

Collegium Pharmaceutical sees FY24 net product revenues of $620M-$635M

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App